OneSkin, founded by Brazilian PhD scientists in 2016, reports that it has now closed a Series A funding round led by Selva Ventures, together with contributions from PLUS Capital, Unilever Ventures, Able Partners, SOSV, and Meta Planet. This brings the accumulated capital of…
Researchers from Johns Hopkins University have recently discovered several prominent biomarkers that allow for the early diagnosis of dementia and/or mild cognitive impairment (MCI). In a recently published article, evidence has been presented that patients with diabetes type 2 exhibited…
Healthcare start-up Tennr reports a $37 million Series B fundraising round – nine months after raising an $18 million Series A funding round. The young company plans to use machine learning in order to improve patient record keeping, prevent medical error and…
MIT researchers have developed a battery-free, subcellular-sized device made of polymer designed to measure and modulate a neuron’s electrical and metabolic activity. When the device is activated by light, it can gently wrap around the neuron cell’s axons and dendrites without…
RegenxBio, a publicly-traded biotech firm, released data this week from a Phase 2 clinical trial designed to test its leading genetic therapy product in patients with bilateral wet age-related macular degeneration (AMD). AMD is characterized by abnormal growth of blood vessels…
Advanced diagnostics company Amprion reports that it has raised $6 million out of a planned $15 million Series B financing round. The funding will help the company promote diagnostic testing for neurodegenerative diseases like Parkinson’s, Alzheimer’s and Lewy body dementia. Amprion’s flagship…
Arda Therapeutics, a company focusing on targeted cell depletion therapies for chronic diseases, completed a successful $43 million Series A financing round led by Andreessen Horowitz, already an investor in the firm, in addition to Two Sigma Ventures, RV Invest,…
Silicon Valley biotech Integrated Biosciences has raised $17.2 million in seed financing to develop therapeutics for age-related diseases. The funding round included Sutter Hill Ventures, Lifespan Vision Ventures, Root Ventures, Civilization Ventures, Illumina Ventures Labs and additional funding sources. Founded in 2022,…
Helaina has announced a successful $45 million Series B funding round, bringing its total equity funding to $83 million, which will be used to further the development of effera Human Lactoferrin, a protein product designed to support women’s health, active nutrition…
Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055, a first-in-class small molecule targeting TNIK (Traf2- and Nck-interacting kinase). ISM001-055 was designed using a unique AI platform to…
